EN DE
Watch VIMAB Group AB for free: we tell you when fair value or trend changes.
Data-driven stock valuation

VIMAB Group AB (VIMAB) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of VIMAB Group AB stock SEK 1.91, price SEK 2.45, that is 22.0% below the price, quality 25 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials SE · ISIN SE0007439633

VG VIMAB Group AB logo Thin data Nov 10, 2026

VIMAB Group AB

VIMAB · ST
Expensive, weak quality

Our calculation puts a fair price 22% below what the stock costs today.

Low debt
Revenue last quarter +16% vs. a year ago.
Expensive Growth (revenue 5y +10.9 %/yr in SEK)
Fair value kr 1.91 · Overvalued
Quality 25/100
Loss-making · -25.1% net margin (TTM)
Negative free cash flow
Trails peers (3/8)
Narrow moat 10/100 · thin data
Thin data
Estimate
Watch VIMAB Group AB for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 48.78 kr 1.85 Fair Value kr 1.91 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range kr 1.85 – kr 48.78 · fair‑value band kr 1.43 – kr 2.39 · the kr 2.45 price screens above the kr 1.91 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow VIMAB Group in your weekly email

Every Wednesday you see whether VIMAB Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Vimab Group AB (publ), together with its subsidiaries, operates in the energy service, and industrial and environmental technology industries in Sweden and internationally.

Show moreShow less

The company sells energy storage systems and fittings, as well as valve or spare part; and manufactures various products, such as portable valve grinding equipment, electric steam boilers, customized steam systems, molds, tooling, prototypes, rollers, shafts, and many other machine components.

It also provides repair and maintenance services for energy-producing industries; valve services; piping services, including industrial pipe welding, steam piping, refrigeration, industrial plumbing, repairs, pipe insulation, and forging; and cutting services.

In addition, the company operates as a mechanical workshop and contract manufacturer for companies in a variety of industries; and build various infrastructure networks, such as fiber and power supply. The company was incorporated in 2011 and is based in Stockholm, Sweden.

Stock analysis

VIMAB Group AB (VIMAB) currently trades at kr 2.45, while our estimate is kr 1.91, 22% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: kr 1.43 (bear) to kr 2.39 (bull), the price of kr 2.45 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 25/100 (below-average quality), in the Industrials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

VIMAB Group AB reported revenue of 313M SEK in FY2025 versus 203M SEK in FY2021, a compound +11.4%/yr. Reported net income was −102M SEK in FY2025.

Key figures

Market cap 117M SEK (≈ $11.8M) Micro · P/S ratio 0.35 · EPS (TTM) kr −2.90 · Net margin −25.1% · Return on equity −42,327% · Return on assets (EBIT) −15.0% (5-year average) · Operating margin −4.0% · Revenue (TTM) 338M SEK.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).

What moves the price

The share trades about 53% below its 52-week high and 32% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −8% fair-value upside, at −22%, VIMAB screens richer than that median.

Fair Value

Bear kr 1.43 Fair Value kr 1.91 Bull kr 2.39
Price kr 2.45 · Downside -22.0%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 25/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 38
How much profit the company makes from its sales and capital
Quality Growth 9
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 32
Debt, balance sheet and risk of trouble
Investment 83
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 5
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 9
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 31/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−3.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.9%
Start year 2020 (pandemic)
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
7.0% (2020) → −20.7% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

VIMAB screens overvalued: fair value 22% below the price. Compare with Verisk Analytics, Inc →

Compare VIMAB Group AB with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Consulting Services · 79 stocks

Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 25 · Bottom 25%
Fair Value upside −22.0% · Bottom 25%
Profitability
Return on assets −39.2% · Bottom 25%
Net margin (12 months) −25.1% · Bottom 25%
Operating margin (12 months) −4.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 15.5% · Top 25%
Balance sheet
Debt / equity 0.02× · Lowest 25%

Valuation Multiplesvs Consulting Services median · lower = cheaper

P/B 3.23× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 0.35× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)4 · sector 35
FUTURE (revenue growth)78 · sector 20
PAST (return on equity)0 · sector 33
HEALTH (low debt)99 · sector 89
DIVIDEND (yield)0 · sector 64

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Consulting Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Booz Allen Hamilton Holding BAH $87.42 $159.98 +83% vs VIMAB
GRG Metrology & Test Group 002967 ¥17.67 ¥19.62 +11% vs VIMAB
Huron Consulting Group HURN $166.47 $177.73 +7% vs VIMAB
Bureau Veritas SA BVI €29.96 €27.88 −7% vs VIMAB
FTI Consulting, Inc FCN $197.34 $182.15 −8% vs VIMAB
DKSH Holding DKSH CHF 77.90 CHF 65.52 −16% vs VIMAB
Verisk Analytics, Inc VRSK $204.02 $148.69 −27% vs VIMAB
SGS SA SGSN CHF 101.90 CHF 70.45 −31% vs VIMAB
Equifax Inc EFX $188.23 $109.01 −42% vs VIMAB
ALS Limited ALQ A$21.51 A$11.18 −48% vs VIMAB

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

VIMAB Group AB: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "VIMAB Group AB Fair Value". https://www.fairvalue-calculator.com/stock/VIMAB

Frequently asked questions

Is VIMAB Group AB (VIMAB) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is kr 1.91 versus a price of kr 2.45, about 22% lower (overvalued).
What is the fair value of VIMAB?
Our estimate for VIMAB Group AB is kr 1.91 (as of Nov 10, 2026), built from audited fundamentals. The current price: kr 2.45.
What is the quality score of VIMAB?
VIMAB Group AB has a Quality Score of 25/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for VIMAB Group AB (VIMAB)?
Our calculated price target is the estimate of kr 1.91 (as of Nov 10, 2026). Cautious scenario kr 1.43, optimistic scenario kr 2.39. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the VIMAB Group AB stock forecast for 2026?
Our estimate puts fair value at kr 1.91, about 22% lower versus a price of kr 2.45 (overvalued). Cautious scenario kr 1.43, optimistic scenario kr 2.39. The calculation is refreshed regularly with new filings.
What is the revenue of VIMAB Group AB (VIMAB)?
VIMAB Group AB reported trailing-twelve-month revenue of about 338M SEK (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of VIMAB Group AB (VIMAB)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For VIMAB Group AB it is kr 1.91 per share (as of Nov 10, 2026), against a price of kr 2.45.
Is VIMAB Group AB stock overvalued or undervalued in 2026?
As of Nov 10, 2026, VIMAB trades above its calculated fair value: price kr 2.45, fair value kr 1.91, a gap of about −22% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of VIMAB?
No. The price is what the market pays today (kr 2.45); the fair value is what the company's own numbers justify (kr 1.91). For VIMAB Group AB the two are kr 0.5400 per share apart. That gap is exactly why we show both numbers side by side.
How much is VIMAB Group AB worth?
The market values VIMAB Group AB at about 117M SEK (market capitalisation, as of Nov 10, 2026). Per share that is kr 2.45; our models calculate a fair value of kr 1.91 per share.
What do the bullish and bearish scenarios say about VIMAB?
Our models span a range for VIMAB Group AB: cautious scenario kr 1.43, base kr 1.91, optimistic kr 2.39 per share (as of Nov 10, 2026, price kr 2.45). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of VIMAB Group AB (VIMAB)?
Balance-sheet figures for VIMAB Group AB (as of Nov 10, 2026): debt of 0.02 per unit of equity. They feed the Quality Score of 25/100, which measures business quality independently of the share price.
How far is VIMAB from its 52-week high?
VIMAB Group AB trades at kr 2.45, about 53% below its 52-week high of kr 5.18 and 32% above the low of kr 1.85 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of kr 1.91 is for.
Which stocks are comparable to VIMAB Group AB?
From the same area (Industrials) we also value Verisk Analytics, Inc, SGS SA, Equifax Inc, Bureau Veritas SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is VIMAB Group AB stock attractive at the current price?
The data as of Nov 10, 2026: price kr 2.45, calculated fair value kr 1.91 (−22%), Quality Score 25/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. VIMAB Group AB itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of VIMAB Group AB (VIMAB)?
The closing price on Nov 10, 2026 was kr 2.45. Our estimate is kr 1.91, about 22% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with VIMAB Group AB right now?
The price sits above even our optimistic bull case (kr 2.39). The favourable scenario is already priced in. Weak quality (25/100) and above fair value at the same time, the margin of safety is missing on both counts. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of VIMAB Group AB

How large is the market capitalisation of VIMAB Group AB (VIMAB)?
The market capitalisation of VIMAB Group AB is 117M SEK (≈ $11.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of VIMAB Group AB (VIMAB)?
The price-to-sales ratio of VIMAB Group AB is 0.35 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of VIMAB Group AB (VIMAB)?
Earnings per share at VIMAB Group AB are kr −2.90. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of VIMAB Group AB (VIMAB)?
The net margin of VIMAB Group AB is −25.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of VIMAB Group AB (VIMAB)?
The return on equity (ROE) of VIMAB Group AB is −42,327% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of VIMAB Group AB (VIMAB)?
On an EBIT basis the return on assets of VIMAB Group AB is −15.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of VIMAB Group AB (VIMAB)?
The operating margin of VIMAB Group AB is −4.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at VIMAB Group AB (VIMAB)?
Revenue at VIMAB Group AB is growing +15.5% versus a year earlier (3y avg +11.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at VIMAB Group AB (VIMAB)?
Earnings per share at VIMAB Group AB are growing −83.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does VIMAB Group AB (VIMAB) generate?
The free cash flow of VIMAB Group AB is −28.0M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does VIMAB Group AB (VIMAB) carry?
The net debt of VIMAB Group AB is 50.3M SEK (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch VIMAB Group AB in the live analysis

One click puts VIMAB Group AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.